Hybrid anisotropic nanostructures for dual-modal cancer imaging and image-guided chemo-thermo therapies
Journal Article
·
· Biomaterials
- Shanxi Medical Univ. (China). Dept. of Radiology of the First Hospital of Shanxi Medical Univ. and Molecular Imaging Precision Medical Collaborative Innovation Center; Stanford Univ., CA (United States). School of Medicine, Molecular Imaging Program at Stanford (MIPS), Canary Center at Stanford for Cancer Early Detection and Dept. of Radiology and Bio-X Program
- Stanford Univ., CA (United States). School of Medicine, Molecular Imaging Program at Stanford (MIPS), Canary Center at Stanford for Cancer Early Detection and Dept. of Radiology and Bio-X Program
- Stanford Univ., CA (United States). Dept. of Chemistry
- Zhejiang Univ., Hangzhou (China). The Second Hospital of Zhejiang Univ. School of Medicine, PET Center and Dept. of Nuclear Medicine
The multimodality theranostic system, which can integrate two or more different therapeutic modalities and multimodal imaging agents into a nanoentity, shows great promising prospects for the cancer treatment. For this, we developed an efficient and novel strategy to synthesize hybrid anisotropic nanoparticles (HANs) with intrinsic multimodal theranostic capability [chemotherapy, photothermal therapy, magnetic resonance imaging (MRI), and photoacoustic imaging (PAI)]. For the first time, under the guidance of MRI and PAI, the chemotherapy and thermotherapy induced by administration of multifunctional hybrid nanoprobes were applied simultaneously to the treatment of colon cancer-bearing mice in vivo.
- Research Organization:
- Stanford Univ., CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH); National Nature Science Foundation of China (NSFC); National Key Basic Research Program of China
- Grant/Contract Number:
- SC0008397; CCNE-TR U54 CA119367; CA151459; P50 CA114747; 81571747; 81371628; 2015CB931800; 2015081035; 2015035; 2015057; 2011CB935801
- OSTI ID:
- 1463085
- Alternate ID(s):
- OSTI ID: 1397090
- Journal Information:
- Biomaterials, Vol. 103, Issue C; ISSN 0142-9612
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Cited by: 34 works
Citation information provided by
Web of Science
Web of Science
Similar Records
Chelator-Free and Biocompatible Melanin Nanoplatform with Facile-Loading Gadolinium and Copper-64 for Bioimaging
Cancer cell membrane-coated rare earth doped nanoparticles for tumor surgery navigation in NIR-II imaging window
Transferring Biomarker into Molecular Probe: Melanin Nanoparticle as a Naturally Active Platform for Multimodality Imaging
Journal Article
·
Thu Jun 08 00:00:00 EDT 2017
· Bioconjugate Chemistry
·
OSTI ID:1463085
+7 more
Cancer cell membrane-coated rare earth doped nanoparticles for tumor surgery navigation in NIR-II imaging window
Journal Article
·
Fri Dec 27 00:00:00 EST 2019
· Chemical Engineering Journal
·
OSTI ID:1463085
+9 more
Transferring Biomarker into Molecular Probe: Melanin Nanoparticle as a Naturally Active Platform for Multimodality Imaging
Journal Article
·
Thu Oct 16 00:00:00 EDT 2014
· Journal of the American Chemical Society
·
OSTI ID:1463085
+8 more